← All stocks

MIMEDX GROUP, INC.

MDXG Net selling
CIK 0001376339 #2922 in the set updated 18 Sep 2026
Bought (120 mo)
$1.94M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$13.57M
$0.00 on a plan · $1.16M straight out of an exercise
Sold at will
$12.41M
71 of 72 sales
Net
−$11.62M
−$10.46M against sales at will

By person

38 insiders · 85 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Okumus Fund Management Ltd. entity
10% owner
$5.59M (6)
−$5.59M
21,066,710
14.45%
$156.22M
−8.6%
Taylor William Charles
President and COO
$2.04M (4) scheduled
−$2.04M
659,253
0.4523%
$4.89M
+16.4%
Capper Joseph H
Chief Executive Officer
$1.91M (3)
+$1.91M
904,656
0.6206%
$6.71M
+8,688%
Hulse William Frank IV
General Counsel and CAO
$1.53M (11)
−$1.53M
543,195
0.3727%
$4.03M
Whitlow Ricci S
Chief Operating Officer
$1.01M (5)
−$1.01M
462,825
0.3175%
$3.43M
+6,927%
Stein Robert Benjamin
President, Regenerative Med.
$907.10K (14)
−$907.10K
317,803
0.2180%
$2.36M
WRIGHT TIMOTHY R
Chief Executive Officer
$904.70K (4)
−$904.70K
1,711,324
1.17%
$12.69M
Maersk-Moller Kimberly
Chief Commercial Officer
$496.61K (4)
−$496.61K
309,630
0.2124%
$2.30M
+107.8%
KOOB CHARLES E
Director
$429.14K (1)
−$429.14K
1,431,525
0.9821%
$10.62M
+5.4%
Carlson Peter M
Chief Financial Officer
$365.34K (8)
−$365.34K
656,435
0.4504%
$4.87M
Kashyap Rohit
President, WC & Surgical
$94.55K (2)
−$94.55K
430,072
0.2951%
$3.19M
Phelan William Lawrence
Chief Accounting Officer
$92.89K (7)
−$92.89K
184,219
0.1264%
$1.37M
Turner Scott M
SVP, Operations & Procurement
$67.06K (3)
−$67.06K
226,643
0.1555%
$1.68M
+222.9%
Graves Mark
SVP & Chief Compliance Officer
$48.87K (3)
−$48.87K
133,608
0.0917%
$990.78K
+186.7%
DOUG RICE
Chief Financial Officer
$35.79K (1)
+$35.79K
399,566
0.2741%
$2.96M
+3,740%
Falcon Fund 2 Holding Company, L.P. entity
10% owner
28,195,249
19.34%
$209.08M
PETIT PARKER H
Chairman & CEO
4,647,422
3.19%
$34.46M
+7.2%
Barry Richard
Director
3,338,135
2.29%
$24.75M
+1.2%
Hack Bruce
Director
1,039,207
0.7130%
$7.71M
+46.9%
Newton Todd
Director
463,684
0.3181%
$3.44M
+1,521%
Landy Mark
EVP & Chief Strategy Officer
379,925
0.2607%
$2.82M
+246.1%
Senken Michael J.
Chief Financial Officer
273,530
0.1877%
$2.03M
+65.1%
BIERMAN JAMES L
Director
263,684
0.1809%
$1.96M
HAWKINS WILLIAM A
Director
254,931
0.1749%
$1.89M
BEHRENS M KATHLEEN
Director
212,771
0.1460%
$1.58M
BORKOWSKI EDWARD
EVP & Interim CFO
191,166
0.1312%
$1.42M
LAURENCIN CATO T
Director
181,923
0.1248%
$1.35M
BLESER JOSEPH G
Director
181,545
0.1246%
$1.35M
+52.1%
DEWBERRY J TERRY
Director
156,787
0.1076%
$1.16M
+141.3%
Haden Alexandra O
General Counsel & Secretary
154,504
0.1060%
$1.15M
+107.6%
PAPASAN LARRY W
Director
148,042
0.1016%
$1.10M
+8.9%
Giuliani Michael J
Director
130,124
0.0893%
$964.95K
YESTON NEIL
Director
126,357
0.0867%
$937.01K
+116.7%
Evans Charles Robert
Director
121,357
0.0833%
$899.93K
+127.7%
GARDNER PHYLLIS
Director
117,024
0.0803%
$867.80K
Olson Tiffany
Director
108,510
0.0744%
$804.67K
PUHY DOROTHY E
Director
108,510
0.0744%
$804.67K
Aguilar Luis A
Director
25,333
0.0174%
$187.86K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 71
Transactions with no price 0
Shares from compensation/vesting 42,227,945
Sales filed before the plan box existed 42
History held since 8 Sep 2016